Study Objectives: The individual prevalence of sleep-disordered breathing (SDB), short sleep duration, and obesity is high and increasing. The study aimed to investigate potential associations between SDB, objective sleep duration, obesity, diabetes and hypertension across genders, and the effect of pre-or post-menopausal status.
Introduction
Obesity is a major factor for sleep-disordered breathing (SDB), diabetes, and systemic hypertension around the world, and their prevalence is increasing [1] [2] [3] . According to recent general population studies, the prevalence of SDB, especially sleep apnea, is high [4] . Furthermore, the increased awareness to SDB has resulted in 14.6-fold increases in the diagnosis of sleep apnea from 0.42 to 6.37 million per year in the United States between 1993 and 2010 [5] . However, the prevalence of SDB markedly differs between men, premenopausal women, and postmenopausal women [6] . Patients with intermittent hypoxemia in the context of SDB are at increased risk of cardiovascular disease (CVD) and metabolic diseases [7, 8] , and sex differences may exist in the putative associations between SDB and cardiometabolic morbidity or overall mortality [9, 10] .
In addition to SDB, there has been convincing evidence that sleep duration is also associated with CVD risk and metabolic morbidities, although the preponderance of the evidence has relied on subjectively reported sleep duration, rather than objective sleep assessments [11] . Although genetic influences clearly determine sleep needs, data from the Centers for Disease Control and Prevention show that between 1985 and 2012, the mean sleep duration has steadily decreased, and the percentage of adults sleeping ≤6 hr a day has increased, further attesting to the impact of social, lifestyle, and environmental factors [12] . In the context of cardiometabolic diseases, the unique impact of obesity is not only well established, but its contributions as a major risk factor of SDB are also definitively defined [3, 7] . Furthermore, recent epidemiological evidence showed a significant association between body mass index (BMI) and sleep duration [11, 13] . Interestingly, an association between SDB and sleep duration was also reported, albeit in small cohorts [14, 15] .
Considering the high prevalence of obesity, SDB, and short sleep duration in the population and their potentially prominent public health implications, it would be of importance to explore the independent contributions of each of these putative risk factors to the presence of diabetes [16] [17] [18] or systemic hypertension [19] [20] [21] . In addition, considering the vast genderrelated differences in SDB prevalence, it would be important to investigate the hypothesis whether such differences modify the strength of such associations, and also whether menopausal status alters such relationships. To investigate this hypothesis, we conducted a population-based study and measured oxygen saturation (SpO 2 ) at night using pulse oximetry along with objective sleep duration assessments using wrist-based actigraphy in men and in pre-and post-menopausal women in the context of the Nagahama study.
Methods

Study participants
The Nagahama study consists of 9850 middle-aged to elderly citizens who were recruited from 2013 to 2016 from the general population living in Nagahama City, a largely rural city of 125 000 inhabitants located in central Japan. Residents aged 34 to 80 years living independently in the community who had no physical impairments or other known dysfunctions were recruited. Women were asked about menopausal status using a questionnaire and were classified as premenopausal (those who answered "no") or postmenopausal (those who answered "yes" for whatever reasons). Study procedures were approved by the ethics committee of Kyoto University Graduate School of Medicine. Written informed consent was obtained from all participants. For more extensive details on the methods, please refer to Supplementary Material.
Assessment of objective sleep duration
Wrist-based actigraphy was performed using the Actiwatch 2 or the Actiwatch Spectrum Plus wrist actigraph (Philips Respironics, Murrysville, PA, USA) worn on participants' nondominant wrist for 7 consecutive days, whereas participants completed a sleep diary over the same period [22] . Data from a minimum of 4 weekdays and 1 weekend day were required for analysis and were averaged [23] . Bed-in time and bed-out time were set by well-trained investigators and manually confirmed based on the sleep diaries and the device light sensor. Total sleep duration (from sleep onset time to wake-up time) and actual sleep duration (sleep duration after exclusion of wake-time after sleep onset from total sleep duration) were determined using the standard factory-default algorithm. Sleep duration was subdivided into three subgroups (<5, 5-7, and ≥7 hr) to include the appropriate number of participants per sleep duration category (Supplementary Table S1 ).
Assessments of SDB
A pulse oximetry (PULSOX-Me300; Konica Minolta, Inc., Tokyo, Japan) was attached to the nondominant wrist during the first 4 nights of sleep. Each oximetry tracing was reviewed by trained staff members. Start and end times of sleep were set according to actigraphy, and actual sleep duration was used for calculation of oxygen desaturation index (ODI). A minimum of 2 nights of oximetry data were required for analysis and were averaged. SDB severity was defined by ODI3% indices as follows: normal, <5 per hour; mild, 5 to <15 per hour; moderate, 15 to <30 per hour; and severe, ≥30 per hour.
Assessment of obesity
We defined obesity categories using BMI values as follows: underweight, <18. 
Assessment of physical activity
The average values of activity counts per minute obtained from actigraphy were used as indicators of daily physical activity. Participants who wore actigraph less than 2 hr during daytime were excluded from the analysis using physical activity.
Definition of diabetes and systemic hypertension
Diabetes was considered present according to ongoing pharmacological treatment with oral antihyperglycemic drugs and/or insulin or hemoglobin A1c ≥6.5% because not all participants undertook fasting tests. Systemic hypertension was considered present according to ongoing pharmacological treatment with antihypertensive drugs or systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg.
Statistics
Values are expressed as mean ± standard deviation, frequency, or medians [interquartile range]. Group differences for continuous variables were assessed by unpaired Student's t-tests or Mann-Whitney U-tests. Group differences for categorical variables were assessed by chi-squared tests. Multiple regression analyses were performed to evaluate the associations between SDB, sleep duration, obesity, diabetes, and systemic hypertension. Due to specific interest in differences of the relationships between these medical outcomes and obesity and SDB across sex and menopausal status groups, sex and menopausal status by SDB and obesity interactions were examined for both outcomes. All models were adjusted for age, sex, alcohol use, and smoking. In addition, ODI3% and BMI were used for adjustment to examine the independent factors for sleep duration. To determine factors associated with diabetes and systemic hypertension, logistic regression analyses were performed including obesity and SDB categories and physical activity. Mediation analyses were conducted to examine whether SDB may mediate the relationship between obesity and diabetes or systemic hypertension [24, 25] . Obesity was defined as those with overweight-to-obese categorized as above. Both the mediator and the outcome models were adjusted for age, sex, alcohol use, smoking, physical activity, and sleep duration. To determine whether indirect effects of obesity through ODI differed based on sex, moderated mediation was examined as outlined by Preacher, Rucker, and Hayes using bootstrapped standard errors and Generalized Structural Equation Modeling [26] . A two-tailed p-value of <0.05 was considered statistically significant. Statistical analyses were performed using JMP Pro 13.0.0 (SAS Institute, Inc., Cary, NC, USA) and Stata Version 14 (Statacorp LP, College Station TX, USA).
Results
Study participants
The study flow is shown in Supplementary Figure S1 . The total sample was comprised of 7051 individuals (men, n = 2274; women, n = 4777) out of the 9850 initial Nagahama study participants. The demographic characteristics and the findings on sleep duration and SDB severity frequencies, along with the prevalence of diabetes and systemic hypertension, are summarized in Figure 1A and B and Supplementary Table S1. Actual sleep duration in premenopausal women was shorter than in postmenopausal women and men ( Figure 1A and Supplementary  Table S1 ). However, the ODI3% was significantly higher in men, compared with women, independent of menopausal status, and the prevalence of moderate-to-severe SDB was 23.7 per cent in men, 9.5 per cent in postmenopausal women, and only 1.5 per cent in premenopausal women (Figure 1B and Supplementary  Table S1 ).
Minimum SpO 2 in each SDB category did not differ among men and pre-and post-menopausal women, and the cumulative percentage of sleep time with SpO 2 <90% did not differ between men and postmenopausal women (Supplementary Table S2 ).
Association between SDB severity and sleep duration
Baseline characteristics of study participants and SDB severity are shown in Table 1 . As the number of participants with severe SDB was small, moderate and severe SDB participants were subsequently merged, and analyzed as one group when treating SDB as a categorical variable. Baseline information according to sleep duration is shown in Supplementary Table S3 . Of note, sleep duration was significantly correlated with reported sleepiness (r = −0.26, p < 0.001).
LogODI3% showed an independent negative association with sleep duration (β = −0.16, p < 0.001). The statistical significance of this association was preserved when participants with severe SDB were excluded (β = −0.14, p < 0.001). When divided by sex, actual sleep duration was significantly shorter according to higher SDB severity in men and postmenopausal women (Supplementary Figure S2A ). An interaction was found between sex and SDB severity (p = 0.007) (Supplementary Figure S3A) , which was also detected, when women were divided according to menopausal status (Supplementary Figure 
Association between sleep duration and BMI
Actual sleep duration according to BMI category is shown in Supplementary Figure S4 . The overweight-to-obese group had significantly shorter objective sleep duration in each sex group compared with all other categories. BMI was negatively independently associated with actual sleep duration (β = −0.07, p < 0.001). When subdivided by sex, sleep duration was significantly shorter according to the higher obesity categories in men and postmenopausal women (Supplementary Figure S2B) , although the BMI by sex grouping interaction was not significant (p = 0.082).
Association with diabetes and systemic hypertension
The prevalence of diabetes and systemic hypertension appeared to be high according to SDB severity in each sex group, which included menopausal status (Table 1) . Neither subjective nor objective short sleep duration was significantly associated with diabetes or systemic hypertension in the initial models when adjusting for age, sex, and SDB, or in final models, and was therefore included only to adjust for this a priori confounder when examining the effects of obesity and SDB.
SDB was significantly associated with diabetes, as both mild and moderate-to-severe SDB groups had significantly higher odds of diabetes compared with the no-SDB group (mild, OR 1.91, 95% CI 1.42-2.57; moderate-to-severe, OR 2.50, 95% CI 1.76-3.55) and systemic hypertension (mild, OR 1.42, 95% CI 1.24-1.63; moderate-to-severe, OR 2.44, 95% CI 1.99-2.99) (Figure 2 ). Being overweight-to-obese was also significantly associated with both diabetes (OR 1.87, 95% CI 1.49-2.33) and systemic hypertension (OR 2.39, 95% CI 2.05-2.78) (Supplementary Figure S5) . A significant interaction was detected between sex grouping and SDB groupings in models predicting diabetes (p < 0.001), suggesting that the relationship between SDB severity and diabetes differed based on sex or menopausal status. When separated by sex grouping (Figure 2) In premenopausal women, the odds ratio for diabetes in the moderate-to-severe SDB group compared with the no-SDB group was higher (OR 28.1, 95% CI 6.35-124.6). In contrast, no such interaction was detected for systemic hypertension, though odds ratios for moderate-to-severe SDB in premenopausal women (OR 3.88, 95% CI 1.42-10.6) appeared higher than those for men (OR 3.11, 95% CI 2.23-4.33) or postmenopausal women (OR 1.96, 95% CI 1.46-2.63). However, the low number of cases of systemic hypertension (n = 131) and diabetes (n = 20) among premenopausal women increases uncertainty for these estimates. No interaction was detected between SDB and obesity categories for diabetes (p = 0.764) or systemic hypertension (p = 0.237).
SDB as a mediator of BMI and diabetes or systemic hypertension
SDB measured as ODI3% was examined as a mediator of the relationship between obesity and both diabetes and systemic hypertension ( Figure 3A ). Direct effects of obesity category on diabetes and systemic hypertension were both significant (p <0.001). Indirect effects of obesity through SDB were also significant for both diabetes and systemic hypertension (p <0.001). Results suggested that 24.0 per cent of the effect of obesity category on diabetes (quasi-Bayesian 95% CI: 18.4-33.8) and 21.5 per cent of the effect on systemic hypertension were mediated by SDB (quasi-Bayesian 95% CI: 19.0-24.6) ( Figure 3B and C).
As in prior analyses, due to the interest in sex differences in these relationships, moderated mediation analysis was used to examine the possibility of sex differences in the mediational role of SDB. This assessed whether the proportion of the potential effect of obesity on diabetes and systemic hypertension differed by sex, and examined whether both the mediator and outcome model paths were moderated by sex. Examination of both mediator and outcome models here corresponds to model 5 in Preacher, Rucker, and Hayes [26] . Bootstrapping utilized 1000 resamples. Results indicated that sex was a significant moderator for both diabetes (p <0.001) and systemic hypertension (p <0.001). Further examination of sex by assessing mediation models for men and women separately indicated that both direct and indirect effects remained significant for all models for men and women (p <0.001). Among men, 15.3 per cent (95% CI: 9.8-29.2) of the potential total effect of obesity group status on diabetes was mediated by SDB. Among women, 27.8 per cent (95% CI: 19.9-40.7) of this potential effect was mediated through SDB, suggesting that more substantial proportion of this relationship may be mediated by SDB in women. For systemic hypertension, 27.0 per cent (95% CI: 22.3-34.1) of the total effect of obesity status was mediated through SDB among men, 16.9 per cent (95% CI: 14.4-20.5) among women ( Figure 3B and C), indicating that a greater proportion of this relationship was mediated for men than women.
Discussion
This study provides important novel evidence on the associations between SDB or obesity and objective sleep duration in the context of gender, and their associations with diabetes and systemic hypertension. Higher severity of SDB or obesity was associated with shorter sleep duration. However, SDB had a significant association with the occurrence of systemic hypertension, especially in men, whereas short sleep duration was not. The severity of SDB had a significant association with diabetes, but only Data are expressed as means ± SD, percentages, or medians [interquartile range]. Data on menopause were unavailable for 32 women. Participants who consumed alcohol 4 or more days per week were defined as frequent alcohol drinkers. Systemic hypertension was considered present when the patient was treated for systemic hypertension or systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg. Diabetes was considered present when the patient was treated for diabetes or hemoglobin A1c ≥6.5%. Total sleep duration (from sleep onset time to wake-up time) by actigraphy and actual sleep duration (sleep duration after exclusion of wake-time after sleep onset from total sleep duration) were determined using the standard factory-default algorithm. Those who wore actigraph less than 2 hr during daytime were excluded from the data on activity counts (n = 47). Those with an Epworth Sleepiness Score >10 were defined as having excessive daytime sleepiness. The ODI3% adjusted for actual sleep duration was used as an indicator of sleep-disordered breathing. among women, and short sleep duration was not significantly associated with diabetes. Although the number of affected individuals was small, the relationship between moderate-to-severe SDB and diabetes appeared to be very strong in premenopausal women. In addition, the relationships between obesity and diabetes and systemic hypertension may be mediated by SDB, but these indirect effects suggest possible sex differences. A greater proportion of the relationship between obesity status and systemic hypertension appears to be mediated by SDB in men, though the opposite is true for diabetes where the independent association is particularly prominent in women. In this population-based study, the prevalence of obesity, short sleep duration, or SDB was high. To the best of our knowledge, this is the first study evaluating concurrently potential associations among these important risk factors including sex difference within a large cohort (n = 7051). Furthermore, sleep duration was measured objectively by actigraphy, whereas the majority of previous data on sleep duration in association with morbidities or mortality were subjective and relied on selfreported questionnaires [27, 28] . Although subjective short sleep duration was not associated with the prevalence of diabetes or systemic hypertension, some previously published evidence supports our data [29, 30] . In addition, subjective sleep duration may be affected by simultaneous recording with actigraphy, i.e. subjective sleep duration may be different when reported in the presence or absence of a concurrent actigraphy recording. In this study, we confirmed that higher ODI3% or higher severity of SDB and obesity was associated with shorter actual sleep duration. It is therefore possible that previous reports on the associations between short sleep duration and morbidity or mortality might be influenced by concomitant SDB and/or obesity. In recent data from the Multi-Ethnic Study of Atherosclerosis (n = 2151), not sleep duration but rather SDB had a significant association with abnormal fasting glucose levels [23] . Also, the Hispanic Community Health Study/Study of Latinos reported that sleep duration was not associated with systemic hypertension after adjustment for covariates including the apnea-hypopnea index [31] . Although sleep duration was tightly correlated with sleepiness (Supplementary Table S3 ), short sleep duration was not independently associated with either diabetes or systemic hypertension in this cohort. As indicated above, comorbid SDB or objectively measured sleep duration might have contributed to the negative results.
SDB was associated with diabetes only in women. Recently, abnormal fasting glycemic levels were reported as associated with OSA, but not with sleep duration [23] , and such findings are concordant with our current results; however, sex differences were not explored. The average age of women with SDB was reported to be older than men, as in this study [32] . Without adjusting for sleep duration, a higher contribution of OSA to diabetes was reported in women [33] . The differences in BMI between normal and moderate-to-severe SDB participants were greater in the pre-and post-menopausal women than in men (Table 1) . Such greater differences in BMI might have contributed to the differences in the risk of diabetes. In addition, a recent meta-analysis showed that self-reported habitual snoring was hypertension in all participants, (F) odds ratios for systemic hypertension in men, (G) odds ratios for systemic hypertension in postmenopausal women, and (H) odds ratios for systemic hypertension in premenopausal women. The 3% oxygen desaturation index is used as an indicator of sleep-disordered breathing, and the severity of sleep-disordered breathing is defined by 3% oxygen desaturation index levels as follows: normal, <5 per hour; mild, 5 to <15 per hour; and moderate-to-severe, ≥15 per hour. Diabetes was considered present when the patient was treated for diabetes or hemoglobin A1c ≥6.5%. Systemic hypertension was considered present when the patient was treated for systemic hypertension or systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg. associated with diabetes only among women, which again reinforces our current findings [34] .
In this study, the odds ratios for associations between SDB and systemic hypertension differed among sexes (postmenopausal women< men< premenopausal women). The impact of the higher baseline prevalence of diabetes and systemic hypertension in men should be taken into consideration (Table 1 ). In addition, based on data on hormone replacement for postmenopausal women [35] or ovariectomized cats [36] , the hypoxic ventilatory response in premenopausal women would be steeper than in postmenopausal women. Obese women were reported to have increased hypoxic and hypercapnic chemosensitivities against weight increase, a finding that was not found in men [37] . In this study, premenopausal women with moderate-to-severe SDB had significantly higher BMI than men or postmenopausal women (Table 1) . Also, hypoxic ventilatory responses in men were reported to be higher than in women [38] . Therefore, the hypoxic ventilatory response in patients with moderate-to-severe SDB in this study would be expected to be higher premenopausal women>men>postmenopausal women. In addition, the indices of hypoxemia were nearly the same in these three groups (Supplementary Table S2 ). Because hypersensitivity of carotid bodies to hypoxia or activation of the carotid sinus nerve is assumed to be mechanistically associated with systemic hypertension [39, 40] , the difference in the association between the progression of SDB and systemic hypertension among sexes might be derived from differences in hypoxic ventilatory responses, an assumption that would need to be explored in future studies.
Although the number of premenopausal participants was sufficient for our analysis (n = 1585), the number of premenopausal women with moderate-to-severe SDB was quite small (n = 23). The low prevalence of SDB in premenopausal women may indicate that the premenopausal defense mechanisms are strong and a considerable degree of obesity is needed to enable the emergence of SDB in premenopausal women; however, once SDB occurs, its harmful associations with diabetes and/or systemic hypertension were tightly bound to the severity of SDB irrespective of obesity ( Table 1 ). The combination of moderate-to-severe SDB, obesity, and high hypoxic ventilatory response in premenopausal obese women with high carotid body activity [39, 40] would therefore be anticipated to worsen the deleterious cardiometabolic consequences of SDB [37] . Therefore, the present study indicates a need for attention to the effect of SDB on the occurrence of systemic hypertension or diabetes in premenopausal women who are obese, a condition that is highly prevalent in pregnancy [41] .
Obesity and SDB were strong risk and independent factors of diabetes and systemic hypertension (Figure 2 and Supplementary Figure S5 ) [18, 19, 21] . However, their direct and indirect effects remained unclear. Based on the mediation analyses, the effects is used as an indicator of sleep-disordered breathing, and those with 3% oxygen desaturation index levels ≥15 per hour were considered as having sleep-disordered breathing. Body mass index is used as an indicator of obesity, and those with body mass index ≥25 kg/m 2 were considered as having obesity. Diabetes was considered present when the patient was treated for diabetes or hemoglobin A1c ≥6.5%. Systemic hypertension was considered present when the patient was treated for systemic hypertension or systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg. of obesity to diabetes or systemic hypertension were attributable to SDB by about 20 per cent. This might explain why treatment of SDB with continuous positive airway pressure (CPAP) contributes to partial improvements in blood pressure or insulin resistance even in the absence of weight loss, but also indicates that the effect of the weight loss is likely larger than the effect of SDB such that weight loss interventions would theoretically be of greater benefit than CPAP alone [42] . In addition, the indirect effects showed sex differences whereby SDB effects on systemic hypertension were 1.6 times greater in men than in women, and the reciprocal effect size was almost double in women than in men in the context of diabetes. Notwithstanding the high priority to address and reduce obesity, our findings indicate that the treatment for SDB may ameliorate systemic hypertension, particularly in men and achieve improved diabetes control particularly among women.
As with most cohort studies, we recognize several limitations. First, the cross-sectional and observational design precludes inferences of causality. Since the study population was exclusively of Asian origin, generalizability of the findings to people from other ethnic backgrounds is limited. However, this first presentation of a large Asian dataset could be useful and relevant not only in Asia, but worldwide. Second, we assessed SDB by pulse oximetry, which obviously cannot discriminate between central and obstructive sleep apnea events. Although polysomnography is the gold standard for diagnosing OSA and is useful for evaluating SDB, polysomnography would have been prohibitively burdensome. Since we calculated the ODI according to objective sleep duration by actigraphy, which is closely concordant with sleep duration as measured by polysomnography, the ODI measured here should not deviate from the corresponding ODI obtained with polysomnography, a problem afflicting many previous studies evaluating ODI in the absence of actual sleep duration. Third, the number of individuals with moderate-to-severe SDB was very small among premenopausal women, which largely diminished the power and possibly the generalizability to this group. Also, diabetes comparisons among menopausal status groups should be interpreted with caution due to the very low number of premenopausal women who suffered from this condition. However, the number of premenopausal women included in the study was large (n = 1585), and the findings reflect actual conditions in this group and might provide accurate representations of outcomes [43] . Fourth, assessments of sleep duration by actigraphy might not be reliable among patients with severe sleep apnea, even though the results of the analysis after excluding severe SDB participants in this study were virtually identical. Therefore, it would appear that performance of actigraphy in quantifying sleep in those with and without sleep apnea is similar [44] . Fifth, due to the observational nature of these data, causal interpretations of the mediation analyses reported here should be avoided or made only with strong caution. Although results suggest that a portion of the relationship between obesity category and diabetes or systemic hypertension may be mediated by SDB, true causal conclusions using these methods require assumptions such as the sequential ignorability assumption, which cannot typically be met by observational data. Potential residual effects that were not included in the model may overestimate the results. Additionally, moderated mediation using bootstrapping may lead to inflated type I error rates [26] . For all these reasons, mediation results should be interpreted with caution. Since this is the first attempt to assess this potentially complex set of relationships through mediation analyses in this population, further research is thus needed to examine these variables under differing conditions and adjusting for a larger set of potential confounders. Sixth, we could not discriminate between sustained hypertension and white coat hypertension.
In conclusion, SDB and obesity were associated with short objective sleep duration. However, only SDB and obesity showed significant independent associations with diabetes and systemic hypertension, with possible gender and menopausal status-related differences in attributable risk emerging. SDB was an independent risk factor of systemic hypertension in the general population with higher risk in men compared with women, and also an independent risk factor for diabetes, particularly in women. In addition, although results must be cautiously interpreted because of the cross-sectional design, SDB indirectly mediated about 20 per cent of the potential effect of obesity on diabetes or systemic hypertension, and its contribution was higher in women in diabetes and in men in systemic hypertension. Although the prevalence was not high, premenopausal women with moderate-to-severe SDB should be evaluated and treated in a timely fashion because the rates of diabetes are likely very high among these women.
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